Emerging in the field of obesity treatment, retatrutide represents a distinct strategy. Unlike many available medications, retatrutide works as a twin agonist, simultaneously affecting both GLP peptide-1 (GLP-1) and https://mattieslwn468030.thezenweb.com/a-novel-retatrutide-a-glp-gip-receptor-agonist-77021552